IRCT20190706044111N18尚未招募未知
A randomized, open label, two treatments, single dose, crossover, bioequivalence study of Dapoxetine 30mg tablet of Alborz Darou Pharm Co., IRAN in comparison of Priligy 30mg tablet of Menarini in 24 healthy adult subjects under fasting condition
Alborzdarou Pharm. Co.0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 50 years（—）
- 性别
- All
入选标准
- •- Aged between 18 - 50 years
- •- Body weight between 50 – 100 kg
- •- Having good health on the basis of medical history and physical & clinical examination
- •- Understand the procedures and give written informed consent
排除标准
- •Subject had undergone surgery of the gastro-intestinal tract
- •Subject had donated a unit of blood or participated in another clinical trial, within the last two months before the first treatment.
- •Subject had a history of drug or alcohol abuse.
- •Subject who smokes more than 10 cigarettes per day.
- •Subject had used any prescription medication within 14 days, or any non-prescription medication within 7 days, before the first treatment.
研究者
相似试验
尚未招募
不适用
Bioequivalence study of Domperidone 10mg tablet of Amin Pharm Co., IRAIRCT20190706044111N24Amin Pharm. Co.48
已完成
不适用
Comparative Bioavailability study of two different formulations of Clozapine in Schizophrenic PatientsCTRI/2016/09/007290JSC Valenta Pharm18
招募中
不适用
Bioequivalence study of Rosuvastatin 40mg tablet of Cosar Pharm Co., IRAHyperlipidemia.Hyperlipidemia, unspecifiedE78.5IRCT20190706044111N19Cosar Pharm. Co.24
已完成
不适用
Bioequivalence study of Rosuvastatin 20mg tablet of Tolidarou Pharm Co., IRAIRCT20190706044111N16Tolidaru Pharmaceutical Company24
尚未招募
Unknown
Bioequivalence study of Famotidine 40mg tablet of Amin Pharm Co., IRAstomach ulcers.histamine H2-receptor blockersT47. 0X3IRCT20190706044111N36Amin Pharm. Co.24